Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11764 | 892 | 37.7 | 84% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
574 | 13610 | STRUMA OVARII//OVARIAN CANCER//OVARIAN NEOPLASMS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OVARIAN CARCINOMAS | Author keyword | 4 | 31% | 1% | 11 |
2 | CANC MONTREAL | Address | 3 | 11% | 3% | 25 |
3 | 6Q27 | Author keyword | 2 | 43% | 0% | 3 |
4 | APOPTOTIC REGULATORS | Author keyword | 1 | 50% | 0% | 2 |
5 | MIXED ENDOMETRIOID SEROUS CARCINOMAS | Author keyword | 1 | 100% | 0% | 2 |
6 | RECURRENT STRUCTURAL CHROMOSOMAL ABNORMALITIES | Author keyword | 1 | 100% | 0% | 2 |
7 | SPORADIC OVARIAN CANCERS | Author keyword | 1 | 100% | 0% | 2 |
8 | GYNECOL CLIN 2 | Address | 1 | 33% | 0% | 3 |
9 | P53 ANTIGEN | Author keyword | 1 | 40% | 0% | 2 |
10 | DIAGNOST ANALYT CYTOMETRY | Address | 1 | 25% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STAGE I CARCINOMAS | 23 | 74% | 2% | 17 |
2 | DELETION UNIT | 15 | 73% | 1% | 11 |
3 | FREQUENT LOSS | 8 | 10% | 8% | 70 |
4 | TUMORS DISTAL | 6 | 80% | 0% | 4 |
5 | ALLELE LOSS | 5 | 12% | 4% | 37 |
6 | ARM 6Q | 3 | 100% | 0% | 3 |
7 | COMMON EPITHELIAL TUMORS | 3 | 33% | 1% | 8 |
8 | UNIFOCAL ORIGIN | 3 | 26% | 1% | 10 |
9 | OVERREPRESENTATION | 3 | 17% | 2% | 16 |
10 | HUMAN BORDERLINE | 3 | 60% | 0% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis | 2009 | 47 | 108 | 41% |
A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors | 2003 | 64 | 132 | 71% |
TP53 and ovarian cancer | 2003 | 83 | 69 | 43% |
Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (Review) | 2000 | 124 | 104 | 34% |
Alteration of cell-cycle regulation in epithelial ovarian cancer | 2008 | 35 | 135 | 24% |
Large-scale genomic analysis of ovarian carcinomas | 2009 | 18 | 52 | 31% |
Mutational spectrum of p53 mutations in primary breast and ovarian tumors | 2004 | 58 | 117 | 31% |
Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies | 2013 | 7 | 151 | 24% |
THE GENETIC-ANALYSIS OF OVARIAN-CANCER | 1995 | 61 | 106 | 70% |
Chemotherapy resistance in ovarian cancer: New molecular perspectives | 1998 | 50 | 97 | 31% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CANC MONTREAL | 3 | 11% | 2.8% | 25 |
2 | GYNECOL CLIN 2 | 1 | 33% | 0.3% | 3 |
3 | DIAGNOST ANALYT CYTOMETRY | 1 | 25% | 0.3% | 3 |
4 | SECT CANC CYTOGENET | 1 | 11% | 0.7% | 6 |
5 | ARIZONA HLTH SCI CANC | 1 | 50% | 0.1% | 1 |
6 | ASSOC HOSP BRUXELLES | 1 | 50% | 0.1% | 1 |
7 | CANC 6401 E THOMAS RD | 1 | 50% | 0.1% | 1 |
8 | CRI 9502EA 2145 | 1 | 50% | 0.1% | 1 |
9 | DDHK | 1 | 50% | 0.1% | 1 |
10 | EPIDEMIOL SCREENING PREVENT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000221835 | ARID1A//CLEAR CELL CARCINOMA//OVARIAN CLEAR CELL CARCINOMA |
2 | 0.0000146685 | OVARIAN SURFACE EPITHELIUM//OVARIAN SURFACE EPITHELIUM OSE//REPROD BIOL PROGRAM |
3 | 0.0000124327 | CLIN BREAST CARE PROJECT//16Q243//CHROMOSOMAL SCANNING |
4 | 0.0000105911 | CSE1L//PHOSPHO CSE1L//CELLULAR APOPTOSIS SUSCEPTIBILITY |
5 | 0.0000102478 | BORDERLINE OVARIAN TUMOR//ENDOSALPINGIOSIS//BORDERLINE OVARIAN TUMORS |
6 | 0.0000099042 | PSAMMOCARCINOMA//PSAMMOMA BODIES//PRIMARY PERITONEAL CARCINOMA |
7 | 0.0000088987 | CHROMOSOME 3Q26//PAN RAS//HUMAN TELOMERASE GENE |
8 | 0.0000076706 | ICB 1 GENE//ICB 1//C1ORF38 GENE |
9 | 0.0000076364 | P53 GENE//P53 MUTANTS//MUTANT P53 |
10 | 0.0000073778 | PRIMARY FALLOPIAN TUBE CARCINOMA//FALLOPIAN TUBE CARCINOMA//OVARIAN DYSPLASIA |